| Title: | Association between metabolic syndrome and kidney cancer risk: a prospective cohort study |
| Journal: | Lipids in Health and Disease |
| Published: | 17 May 2024 |
| Pubmed: | https://pubmed.ncbi.nlm.nih.gov/38760801/ |
| DOI: | https://doi.org/10.1186/s12944-024-02138-5 |
| URL: | https://lipidworld.biomedcentral.com/counter/pdf/10.1186/s12944-024-02138-5 |
Publication 12056
WARNING: the interactive features of this website use CSS3, which your browser does not support. To use the full features of this website, please update your browser.
Abstract
BackgroundKidney cancer has become known as a metabolic disease. However, there is limited evidence linking metabolic syndrome (MetS) with kidney cancer risk. This study aimed to investigate the association between MetS and its components and the risk of kidney cancer.MethodsUK Biobank data was used in this study. MetS was defined as having three or more metabolic abnormalities, while pre-MetS was defined as the presence of one or two metabolic abnormalities. Hazard ratios (HRs) and 95% confidence intervals (CIs) for kidney cancer risk by MetS category were calculated using multivariable Cox proportional hazards models. Subgroup analyses were conducted for age, sex, BMI, smoking status and drinking status. The joint effects of MetS and genetic factors on kidney cancer risk were also analyzed.ResultsThis study included 355,678 participants without cancer at recruitment. During a median follow-up of 11 years, 1203 participants developed kidney cancer. Compared to the metabolically healthy group, participants with pre-MetS (HR= 1.36, 95% CI: 1.06-1.74) or MetS (HR= 1. 70, 95% CI: 1.30-2.23) had a significantly greater risk of kidney cancer. This risk increased with the increasing number of MetS components (P for trend < 0.001). The combination of hypertension, dyslipidemia and central obesity contributed to the highest risk of kidney cancer (HR= 3.03, 95% CI: 1.91-4.80). Compared with participants with non-MetS and low genetic risk, those with MetS and high genetic risk had the highest risk of kidney cancer (HR= 1. 74, 95% CI: 1.41-2.14).ConclusionsBoth pre-MetS and MetS status were positively associated with kidney cancer risk. The risk associated with kidney cancer varied by combinations of MetS components. These findings may offer novel perspectives on the aetiology of kidney cancer and assist in designing primary prevention strategies.</p>
5 Authors
- Lin Wang
- Han Du
- Chao Sheng
- Hongji Dai
- Kexin Chen
1 Application
| Application ID | Title |
|---|---|
| 76092 | Uncovering the causal mechanism between environmental exposure and cancer by integrating exposome, genomic, clinical phenomic and radiomic data |
Enabling scientific discoveries that improve human health